Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
Autolus reported Q2 net product revenue of $45.7 million, up 119% year-over-year, with gross margin improving to 55% from 6% in the prior quarter. The company raised full-year 2026 revenue guidance to $140-$150 million and secured a five-year, $250 million credit facility with Perceptive Advisors, extending its cash runway into Q2 2028.
Key figures
- Revenue
- 45700000
- Guidance
- $140 million - $150 million (raised from $120 million - $135 million)
- Revenue Yoy
- 119%
- Gross margin
- 55%
- Cash position
- 201600000
- Credit facility
- 250000000
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.